Literature DB >> 9677174

Lack of pharmacokinetic interaction between nelfinavir and nevirapine.

G Skowron, G Leoung, B Kerr, A Dusek, R Anderson, S Beebe, R Grosso.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9677174     DOI： 10.1097/00002030-199810000-00017

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  9 in total

1.  Single and multiple dose pharmacokinetics of nelfinavir and CYP2C19 activity in human immunodeficiency virus-infected patients with chronic liver disease.

Authors:  Y Khaliq; K Gallicano; I Seguin; K Fyke; G Carignan; D Bulman; A Badley; D W Cameron
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

Review 2.  Nevirapine: a review of its use in the prevention and treatment of paediatric HIV infection.

Authors:  A Bardsley-Elliot; C M Perry
Journal:  Paediatr Drugs       Date:  2000 Sep-Oct       Impact factor: 3.022

Review 3.  Delavirdine: clinical pharmacokinetics and drug interactions.

Authors:  J Q Tran; J G Gerber; B M Kerr
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 4.  Nelfinavir: an update on its use in HIV infection.

Authors:  A Bardsley-Elliot; G L Plosker
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

Review 5.  Clinical pharmacokinetics of non-nucleoside reverse transcriptase inhibitors.

Authors:  P F Smith; R DiCenzo; G D Morse
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 6.  Drug interactions of HIV protease inhibitors.

Authors:  L I Malaty; J J Kuper
Journal:  Drug Saf       Date:  1999-02       Impact factor: 5.606

7.  A population pharmacokinetic analysis of nelfinavir mesylate in human immunodeficiency virus-infected patients enrolled in a phase III clinical trial.

Authors:  K A Jackson; S E Rosenbaum; B M Kerr; Y K Pithavala; G Yuen; M N Dudley
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

Review 8.  Nevirapine: pharmacokinetic considerations in children and pregnant women.

Authors:  M Mirochnick; D F Clarke; A Dorenbaum
Journal:  Clin Pharmacokinet       Date:  2000-10       Impact factor: 6.447

9.  Pharmacokinetic modelling of the placental transfer of nelfinavir and its M8 metabolite: a population study using 75 maternal-cord plasma samples.

Authors:  Déborah Hirt; Saïk Urien; Vincent Jullien; Ghislaine Firtion; Hélène Chappuy; Elisabeth Rey; Gérard Pons; Laurent Mandelbrot; Jean-Marc Treluyer
Journal:  Br J Clin Pharmacol       Date:  2007-09-24       Impact factor: 4.335
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.